obesity-995x60.png
FEATURED ARTICLES
Synaptic Regeneration And The Future Of Alzheimer's R&D
For too long, treating Alzheimer’s disease has been a case of “managed decline.” We need to move beyond slowing disease progression toward achieving tangible functional recovery.
-
![Josh Rose Headshot]( "Can Independent Pharmacies Succeed Where Walgreens Failed?")
Can Independent Pharmacies Succeed Where Walgreens Failed?Josh Rose, CEO of Hawthorne Health, believes independent community pharmacies may succeed where large retail chains struggled in clinical research. In this interview, Rose explains how Hawthorne is building pharmacy-based trial sites focused on underserved communities, chronic disease studies, and trusted patient relationships.
-
![June 8 Parexel eBlast Image resize]( "Timing And Data Are Critical To Winning BTD For Rare Disease Drugs")
Timing And Data Are Critical To Winning BTD For Rare Disease DrugsBreakthrough Therapy designation (BTD) can accelerate rare disease drug development—but timing and evidence are everything. Learn how to position your program for FDA success.
-
![CTD story - GettyImages-1253880092 and Canva]( "How Did You End Up In Clinical Research?")
How Did You End Up In Clinical Research?To commemorate Clinical Trials Day, we asked clinical researchers to share their story, answering, "How did you get into clinical research?"
SERVICES AND PRODUCTS
With ParexelAI™, you're not just optimizing your current development timeline, you're unlocking the ability to run more programs simultaneously across our global network and compress critical timelines. In a landscape where speed to market directly impacts patient outcomes, ParexelAI empowers you to innovate and make a meaningful difference in patients' lives.
Streamline clinical trial data capture through eSource workflows that support both Direct Data Capture and automated EHR-to-EDC data transfer across Paradigm Health’s research-ready provider network.
Research teams can capture study data within the EHR or through a standalone application, enabling consistent workflows across sites while reducing manual transcription. Sponsors gain faster access to cleaner trial data with fewer queries and more efficient monitoring.
With 150+ active sites and partner networks, Altasciences connects your clinical study to optimal locations and patients to reduce risk, accelerate enrollment, and stay on track.
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.